| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/25/2002 | USRE37767 Highly stable recombinant yeasts for the production of recombinant proteins |
| 06/25/2002 | USRE37766 K. lactis pyruvate-decarboxylase promoter and use thereof |
| 06/25/2002 | US6410828 Nucleotide sequences for use as tools in controlling preferential gene expression in plants |
| 06/25/2002 | US6410825 Genetically engineered rodent; for use as animal model in evaluating animal fertility defects |
| 06/25/2002 | US6410775 APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies |
| 06/25/2002 | US6410722 Nucleotide sequences associate with replication; for use as tool in genetic engineering |
| 06/25/2002 | US6410720 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 06/25/2002 | US6410719 Nuclelotide sequences coding adhesin for use in the treatment of gastrointestinal disorders and peptic ulcers |
| 06/25/2002 | US6410717 Nucleotide sequences coding preferential protein for use in generation of disease resistant plants |
| 06/25/2002 | US6410714 Canine low affinity IgE receptor (CD23) nucleic acid molecules and uses thereof |
| 06/25/2002 | US6410713 Nucleotide sequences coding chaperone protein for use in the prevention and treatment of cancer, stress and heart defects |
| 06/25/2002 | US6410712 Nucleotide sequences coding preferential polypeptide for use in treatment of sleep disorder |
| 06/25/2002 | US6410711 Nucleotide sequences coding preferential polypeptide for use in human therapeutics and diagnostics |
| 06/25/2002 | US6410710 Nucleotides sequences coding protein for use in treatment of autoimmune response defects |
| 06/25/2002 | US6410709 Polypeptide; for use in diagnosis and treatment of inflammatory and cell proliferative disorders |
| 06/25/2002 | US6410708 Nucleotide sequences coding preferential protein for use in the diagnosis and treatment of inflammation, cancer and inflammatory bowel disease |
| 06/25/2002 | US6410707 Forming fusion protein which includes target sequence linked to carbonic anhydrase through cleavage site and cleaving fusion protein with cleavage reagent to produce first polypeptide including target sequence |
| 06/25/2002 | US6410706 Nucleic acid encoding chitin-binding receptor kinase |
| 06/25/2002 | US6410705 Nucleotide sequences coding enzymatic polypeptide for use in the generation of threonine; for use in preparation of animal nutrients, human medicine and pharmacology |
| 06/25/2002 | US6410704 Nucleotide sequences coding enzymatic polypeptide for use in treatment of viral disease |
| 06/25/2002 | US6410703 Identification of a vaccine candidate from an extraintestinal isolate of E. coli |
| 06/25/2002 | US6410701 Human neuropeptide receptor |
| 06/25/2002 | US6410697 Isolating mammalian glycoprotein; obtain sample with glycoprotein, incubate with antibody, apply solution to matrix, elute and recover mammalian glycoprotein |
| 06/25/2002 | US6410696 Cyclosporin immunoassay |
| 06/25/2002 | US6410694 Naturation of a somatotropin; obtain somatotropin, incubate with detergent, recover somatotropin and remove detergent |
| 06/25/2002 | US6410693 Inhibitors of the JNK signal transduction pathway and methods of use |
| 06/25/2002 | US6410691 Monoclonal antibody for use in diagnosis and treatment of immunlogical defects, cancer and rheumatic diseases |
| 06/25/2002 | US6410690 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 06/25/2002 | US6410689 Caspase recruitment domain polypeptides |
| 06/25/2002 | US6410688 Def1 |
| 06/25/2002 | US6410686 Galanin receptor 2 protein |
| 06/25/2002 | US6410598 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
| 06/25/2002 | US6410516 Nuclear factors associated with transcriptional regulation |
| 06/25/2002 | US6410514 Tissue specific prodrug |
| 06/25/2002 | US6410513 Polypeptides |
| 06/25/2002 | US6410510 Administration modified ciliary neurotrophic factors |
| 06/25/2002 | US6410508 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 06/25/2002 | US6410507 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/25/2002 | US6410506 Transforming growth factor α HII |
| 06/25/2002 | US6410326 Destroying human tumor cells; obtain tumor cells, transform with replication defective vector, incubate with prodrug, monitor destruction of cells |
| 06/25/2002 | US6410319 CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies |
| 06/25/2002 | US6410318 Antibodies directed against binding-associated epitopes |
| 06/25/2002 | US6410316 Methods for producing a vector producing cell line utilizing a high multiplicity of transduction |
| 06/25/2002 | US6410312 huBUB3 gene involved in human cancers |
| 06/25/2002 | US6410299 Attenuated forms of bovine viral diarrhea virus |
| 06/25/2002 | US6410297 Processes for preparation of Marek's disease virus using continuous avian cell lines |
| 06/25/2002 | US6410296 Herpes virus proteinase and method of assaying |
| 06/25/2002 | US6410272 Production of thrombin inhibitors |
| 06/25/2002 | US6410269 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 06/25/2002 | US6410268 Polynucleotides encoding chemokine alpha-3 |
| 06/25/2002 | US6410267 Human GTPase-associated proteins |
| 06/25/2002 | US6410265 Efficient production of p-hydroxybenzoic acid; culture pseudomonas, in the presence toluene, benzoic acid, p-hydroxybenzyl alcohol, p-hydroxybenzaldehyde or p-cresol, recover p-hydroxybenzoic acid |
| 06/25/2002 | US6410264 Pichia pastoris gene sequences and methods for their use |
| 06/25/2002 | US6410262 Secretion factors for gram-positive microorganisms genes encoding them and methods of using it |
| 06/25/2002 | US6410261 CIITA-interacting proteins and methods of use therefor |
| 06/25/2002 | US6410255 Optical probes and assays |
| 06/25/2002 | US6410249 Odorant receptors |
| 06/25/2002 | US6410247 Nuclear matrix protein fluid assay |
| 06/25/2002 | US6410245 Complexing; fusion proteins; quantitative analysis |
| 06/25/2002 | US6410240 Complexing |
| 06/25/2002 | US6410238 Hybrid nucleic acids; cancer diagnosis |
| 06/25/2002 | US6410237 DNA encoding canine von Willebrand factor and methods of use |
| 06/25/2002 | US6410232 Molecules of the follistatin-related protein family and uses thereof |
| 06/25/2002 | US6410224 Cleavage of protein using enzyme; therapy for inflammation, asthma, rheumatic diseases, autoimmune diseases |
| 06/25/2002 | US6410221 Entomopoxvirus expression system |
| 06/25/2002 | US6410032 Attenuated forms of bovine viral diarrhea virus |
| 06/25/2002 | US6410030 Polypeptide used as immunogenic element carried by peptide sequence between amino acid residues 130 and 230 of sequence of g protein of human respiratory syncytial virus of subgroups a and b, or of bovine respiratory syncytial virus |
| 06/25/2002 | US6410028 Administering complex of heat shock protein noncovalently bound to antigenic peptide or protein to elicit immune response, wherein complex is made in vitro, and antigenic peptide or protein is not isolated from complex |
| 06/25/2002 | US6410027 Methods for preparation of vaccines against cancer |
| 06/25/2002 | US6410026 Preparing rna from isolated cancer cells, making cdna, introducing into host cells, culturing cells to express cancer-derived cdnas, purifying heat shock protein-peptide complexes obtained, administering to treat cancer |
| 06/25/2002 | US6410024 Epitopes of shigella like toxin and their use as vaccine and in diagnosis |
| 06/25/2002 | US6410023 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
| 06/25/2002 | US6410022 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 06/25/2002 | US6410014 Administering protein-tyrosine kinase chimeras capable of directing cytotoxic t lymphocytes to specifically recognize and lyse target cells |
| 06/25/2002 | US6410010 Recombinant P53 adenovirus compositions |
| 06/25/2002 | US6410009 Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
| 06/25/2002 | US6410008 Chimeric IL-10 proteins and uses thereof |
| 06/25/2002 | US6409648 Polynucleotides encoding TRF1 binding proteins |
| 06/25/2002 | US6408536 Process for drying protein crystals |
| 06/25/2002 | CA2201587C Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 06/25/2002 | CA2146712C Cold induced promoter from winter brassica napus |
| 06/25/2002 | CA2140281C Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 06/25/2002 | CA2123612C Hybrid protein between cs from plasmodium and h bsag |
| 06/25/2002 | CA2095300C Use of genetically modified cells to treat defects, disease or damage of the central nervous system |
| 06/25/2002 | CA2094347C A method of producing a factor viii preparation |
| 06/25/2002 | CA2085881C Dna encoding mammalian phosphodiesterases |
| 06/25/2002 | CA2081659C Recombinant human factor viii derivatives |
| 06/25/2002 | CA2036814C Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/25/2002 | CA2017379C Purification and characterization of a glioma-derived growth factor |
| 06/25/2002 | CA2006412C Eimeria tenella vaccine |
| 06/23/2002 | WO2002040654A2 A human serpin secreted from lymphoid cells lsi-01 |
| 06/23/2002 | CA2429179A1 Polynucleotide encoding a novel human serpin secreted from lymphoid cells lsi-01 |
| 06/21/2002 | CA2327189A1 Novel dna-based vaccine against the encephalitis alphaviruses |
| 06/21/2002 | CA2326749A1 Nucleic acid encoding ion transporter component protein |
| 06/20/2002 | WO2002048708A2 Assay for anti-viral agent |
| 06/20/2002 | WO2002048671A1 Assay for paralytic shellfish toxin |
| 06/20/2002 | WO2002048391A2 Dormancy - induced mycobacterium proteins |
| 06/20/2002 | WO2002048388A2 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 06/20/2002 | WO2002048384A2 Nucleic acid sequence 'm73791' serving as a human gene, and derivatives thereof |
| 06/20/2002 | WO2002048382A2 Method for the production of a heterologous protein by a fungus |